Dieter Kabelitz, M.D. was a full professor at the University of Kiel and director of the Institute of Immunology from 1999 to 2018, where he continues to work as a senior research group leader. Previously, he was head of the department of immunology at the Paul-Ehrlich-Institute, Langen, Germany, and associate professor at the University of Heidelberg, Germany. From 2011 to 2012 he served as president of the German Society for Immunology (DGfI). He was a council member of the International Union of Immunological Societies (IUIS) and is the current chair of the Education Committee (EDU) of IUIS. His scientific expertise is in the field of the functional characterization of human gamma delta T cells. Prof. Kabelitz’ major interest is to explore strategies around increasing the effector functions of gamma delta T cells for the potential use in immunotherapy of cancer. Prof. Kabelitz has more than 30 years of research experience in immunology and has published more than 390 papers in peer-reviewed journals and edited or co-edited several books.